An interventional study of Gaze-contingent feedback in Anxiety Disorders, sponsored by Tel Aviv University. Completed at 1 site in Israel. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2018-09-18.
Sponsored by Tel Aviv University · Not applicable, Interventional, and Treatment
The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of anxiety disorders in children.
Attention biases in threat processing have been assigned a prominent role in the etiology and maintenance of anxiety disorders. The purpose of this study is to determine whether giving gaze-contingent feedback is an effective treatment for anxiety disorders in clinically anxious 6-10 year-olds children. Participants will be assessed using clinical interviews and parent- and self-rated questionnaires before and after eight training sessions. Outcome measures will be anxiety symptoms and depression as measured by gold standard questionnaires as well as structured clinical interviews with children and their parents. Attentional threat bias and Attentional control will also be measured to explore potential mediators of ABMT's effect on anxiety.
4,864 studies on the registry are indexed under Anxiety Disorders; 1,388 are open to participants now.
This study's enrollment of 12 is below the median of 80 across 4,170 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Tel Aviv University is the lead sponsor of 100 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Exclusion Criteria: To be excluded youth must:
Participants will receive gaze-contingent feedback according to their viewing patterns
Behavioral: Gaze-contingent feedback
Participants will receive gaze-contingent feedback according to their viewing patterns
Change from baseline in anxiety symptoms - the Pediatric Anxiety Rating (PARS)
The PARS assesses global anxiety severity across different anxiety disorders in children
Time frame: Post treatment (1 week after treatment completion)
Change from baseline in anxiety related emotional disorders symptoms - Child/Parent (the SCARED 41-item)
The SCARED is a 41-item self and parent-report instrument designed to assess anxiety in children.
Time frame: Post treatment (1 week after treatment completion)
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tel Aviv University